IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Chelsea Therapeutics Contingen

CUSIP: 163ESC908 | 2 institutional holders

Quarters

Q1 2018Q4 2017Q3 2017Q2 2017Q1 2017
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2018

Tocqueville Asset Management L.P.80,000
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Tocqueville Asset Management L.P.
80,000$00.0%CoreLowNew York, NY2018-05-14